The clinical relevance of the Pin1/mutp53 axis is further supported by our analysis of a cohort of breast cancer patients, in which we could establish that the prognostic value of p53 status is conditioned by Pin1 levels. This evidence concerns the gene PIN1 and breast carcinoma.